Genomcore and DIPCAN transform metastatic cancer treatment in Spain
Revolutionizing metastatic cancer treatment: DIPCAN study empowers patients with free genomic analysis and AI insights from 2000 participants.

Revolutionizing metastatic cancer treatment: DIPCAN study empowers patients with free genomic analysis and AI insights from 2000 participants.